Cytel Inc. Adaptive Confirmatory Trial Design Presented at American Society of Clinical Oncology 2011 Now Available for Download  
7/7/2011 9:52:05 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cytel Inc., a leading provider of adaptive clinical trial services and statistical software, in conjunction with Sunesis Pharmaceuticals, today announced the immediate availability for download of the jointly authored Sunesis VALOR trial poster presented at the June 2011 American Society of Clinical Oncology (ASCO) Annual Meeting. The PDF is now accessible to all from this link.